Related Experiment Videos

Distinct changes in pulmonary surfactant homeostasis in common beta-chain- and GM-CSF-deficient mice

J A Reed1, M Ikegami, L Robb

  • 1Children's Hospital Medical Center, Cincinnati, Ohio 43229-3039, USA.

Insights

Granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling is crucial for lung surfactant homeostasis. Genetic inactivation of GM-CSF or its receptor in mice revealed distinct impacts on surfactant metabolism and clearance, offering insights into pulmonary alveolar proteinosis.

Area of Science:

  • Pulmonary medicine
  • Cell biology
  • Genetics

Background:

  • Pulmonary alveolar proteinosis (PAP) is linked to impaired granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling.
  • GM-CSF plays a vital role in maintaining surfactant homeostasis in the lungs.

Purpose of the Study:

  • To investigate phenotypic differences in surfactant metabolism between mice lacking GM-CSF (GM(-/-)) and those lacking its receptor's common beta-chain (beta(c)(-/-)).
  • To elucidate the role of GM-CSF signaling in surfactant clearance and homeostasis.

Main Methods:

  • Comparative analysis of surfactant phospholipid and protein metabolism in wild-type, GM(-/-), and beta(c)(-/-) mice.
  • Assessment of surfactant pool sizes, clearance rates after intratracheal injection, and protein-to-lipid ratios in bronchoalveolar lavage fluid (BALF).

Main Results:

  • Histology was similar, but surfactant metabolism and clearance differed significantly between GM(-/-) and beta(c)(-/-) mice.
  • Lung saturated phosphatidylcholine (Sat PC) levels increased with age in mutant mice, with a more pronounced effect in GM(-/-) mice.
  • Clearance defects were more severe in GM(-/-) than beta(c)(-/-) mice, and SP-D to Sat PC ratios were elevated in both mutant groups.

Conclusions:

  • GM-CSF signaling critically regulates surfactant homeostasis and clearance.
  • Distinct differences in surfactant metabolism between GM(-/-) and beta(c)(-/-) mice suggest alternative clearance pathways.
  • Findings provide a molecular basis for varying PAP symptom severity.

Related Concept Videos